Even within sectors, such as the biotechnology stocks, we can see divergences starting to rack up.
ANIK is a long idea mentioned in my Strategy Sessions and on my videos of late. The first daily chart, below, shows a strong base breakout attempt this morning.
GILD is a major biotech which enjoyed a sharp rally since the April lows. However, with today’s action there is still major topping out potential in play.
Elsewhere, WYNN remains quite weak, while YELP is trying to carve out a base bottom with a $69 upside trigger.
________________________________________________________________
________________________________________________________________
I am liking the looks of TOUR.
Nice over $18.
Agrued.